SOURCE: Nanosphere

Nanosphere to Present at the 34th Annual Cowen & Company Health Care Conference

NORTHBROOK, IL—February 26, 2014 - Nanosphere, Inc. (NASDAQ: NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that that an overview of the company's business and commercial strategy will be given by Michael McGarrity, President and Chief Executive Officer, at the Cowen & Company 34th Annual Health Care Conference, being held at the Boston Marriott Copley Place in Boston, Massachusetts, March 3-5, 2014.

 

Details of the presentation are as follows:
Date: Tuesday, March 4, 2014
Time: 11:20am Eastern Time
Webcast: http://wsw.com/webcast/cowen16/NSPH
Location: Boston Marriott Copley Place

 

About Nanosphere, Inc.
Nanosphere is enhancing medicine through targeted molecular diagnostics that result in earlier disease detection, optimal patient treatment and improved healthcare economics. The Company's versatile technology platform, the Verigene® System, enables clinicians to rapidly detect the most complex, costly and deadly infectious diseases through a low cost and simple-to-use multiplexed diagnostic test. The combination of this innovative technology and Nanosphere's customer-driven solutions keeps commitment to the patient at the forefront of its business. Nanosphere is based in Northbrook, IL. Additional information is available at http://www.nanosphere.us.

 

Except for historical information, the matters discussed in this press release are "forward-looking statements" and are subject to risks and uncertainties. Actual results could differ materially from these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the following: (i) Nanosphere's ability to develop commercially viable products; (ii) Nanosphere's ability to achieve profitability; (iii) Nanosphere's ability to produce and market its products; (iv) Nanosphere's ability to obtain regulatory approval of its products; (v) Nanosphere's ability to protect its intellectual property; (vi) competition and alternative technologies; and (vii) Nanosphere's ability to obtain additional financing to support its operations. Additional risks are discussed in the Company's current filings with the Securities and Exchange Commission. Although the Company believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. The forward-looking statements are made as of the date of this press release, and we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

 

Contacts
Investors:
Roger Moody
Chief Financial Officer
Nanosphere, Inc.
847-400-9021
rmoody@nanosphere.us

Michael Rice
Founding Partner
LifeSci Advisors
646-597-6979
mrice@lifesciadvisors.com

Media:
Lindsey Saxon
Director of Communications
Nanosphere, Inc.
847-400-9173
lsaxon@nanosphere.us

 

 

SOURCE: Nanosphere